Autonomix Medical, Inc.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| Gross Margin | — | — | — | — |
| Operating Expenses | ||||
| Research & Development | $7.1M | $4.7M | $2.2M | $745.0K |
| SG&A Expense | $9.9M | $6.9M | $5.2M | $1.2M |
| Operating Income | $-17.0M | $-11.6M | $-12.0M | $-2.0M |
| Operating Margin | — | — | — | — |
| Interest Expense | — | — | — | — |
| Pretax Income | $-16.7M | $-11.4M | $-15.4M | $-2.0M |
| Income Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $-16.7M | $-11.4M | $-15.4M | $-2.0M |
| Net Margin | — | — | — | — |
| EPS (Basic) | $-2.32 | $-6.46 | $-3.71 | $-0.04 |
| EPS (Diluted) | — | — | — | — |
| Shares Outstanding (Basic) | 7.2M | 1.8M | 4.2M | 48.1M |
| Shares Outstanding (Diluted) | 7.2M | 1.8M | 4.2M | 48.1M |
| Dividends Per Share | — | — | — | — |